0001062993-22-024356.txt : 20221221
0001062993-22-024356.hdr.sgml : 20221221
20221221192836
ACCESSION NUMBER: 0001062993-22-024356
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221219
FILED AS OF DATE: 20221221
DATE AS OF CHANGE: 20221221
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Heffernan Michael Thomas
CENTRAL INDEX KEY: 0001448914
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37372
FILM NUMBER: 221479502
MAIL ADDRESS:
STREET 1: C/O CORNERSTONE THERAPEUTICS INC.
STREET 2: 1255 CRESCENT GREEN DRIVE, SUITE 250
CITY: CARY
STATE: NC
ZIP: 27518
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: COLLEGIUM PHARMACEUTICAL, INC
CENTRAL INDEX KEY: 0001267565
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: VA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 TECHNOLOGY CENTER DRIVE
CITY: STOUGHTON
STATE: MA
ZIP: 02072
BUSINESS PHONE: 781-713-3699
MAIL ADDRESS:
STREET 1: 100 TECHNOLOGY CENTER DRIVE
CITY: STOUGHTON
STATE: MA
ZIP: 02072
FORMER COMPANY:
FORMER CONFORMED NAME: COLLEGIUM PHARMACEUTICAL INC
DATE OF NAME CHANGE: 20031020
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0306
4
2022-12-19
0001267565
COLLEGIUM PHARMACEUTICAL, INC
COLL
0001448914
Heffernan Michael Thomas
C/O COLLEGIUM PHARMACEUTICAL, INC.
100 TECHNOLOGY CENTER DRIVE
STOUGHTON
MA
02072
1
0
0
0
Common Stock
2022-12-19
4
M
0
3606
16.150
A
31629
D
Common Stock
2022-12-19
4
S
0
3606
23.04
D
28023
D
Common Stock
2022-12-20
4
M
0
33758
16.150
A
61781
D
Common Stock
2022-12-20
4
S
0
33758
23.08
D
28023
D
Common Stock
2022-12-21
4
M
0
46600
16.15
A
74623
D
Common Stock
2022-12-21
4
S
0
46600
23.11
D
28023
D
Stock Option (Right to Purchase)
16.150
2022-12-19
4
M
0
3606
0
D
2026-01-20
Common Stock
3606
105399
D
Stock Option (Right to Purchase)
16.150
2022-12-20
4
M
0
33758
0
D
2026-01-20
Common Stock
33758
71641
D
Stock Option (Right to Purchase)
16.150
2022-12-21
4
M
0
46600
0
D
2026-01-20
Common Stock
46600
25041
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2022.
The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.00 to $23.11, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2).
The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.00 to $23.33, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3).
The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.00 to $23.40, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4).
The option, initially representing a right to purchase a total of 109,005 shares, is fully vested and exercisable.
/s/ Colleen Tupper as Attorney-In-Fact For Michael T. Heffernan
2022-12-21